Tata Elxsi has signed a Memorandum of Understanding (MoU) with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, an Institution of National Importance under the Department of Science and Technology (DST), Government of India, to collaborate on the development of next-generation healthcare solutions.
The collaboration combines SCTIMST's strengths in cardiovascular sciences, neurosciences, biotechnology, and clinical sciences with Tata Elxsi's expertise in product engineering, design, AI, and digital technologies. Together, the organisations will address opportunities across diagnostics, medical imaging, digital health, biomedical engineering, medical devices, and related healthcare technologies for India and global markets.
Unlike traditional industry-academia engagements, the partnership creates an extended innovation and engineering environment for Tata Elxsi, its customers, and healthcare partners. It brings together clinicians, specialist researchers, advanced laboratories, prototyping infrastructure, and product engineering capabilities within a single collaborative ecosystem. This will enable MedTech companies to develop, validate, and scale new products more efficiently. The partnership also strengthens capabilities in biocompatibility, toxicology, and other areas.
Tata Elxsi is a global design and technology services company and works with customers across industries such as automotive, broadcast, healthcare and telecom for product and software development.
| Company Name | CMP |
|---|---|
| TCS | 2397.80 |
| Infosys | 1105.75 |
| HCL Technologies | 1319.10 |
| Wipro | 181.10 |
| Tech Mahindra | 1635.15 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: